Untitled

被引：2

作者：

Garfield, D ^{[1
]}

机构：

[1] Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA

来源：

LUNG CANCER | 2006年 / 52卷 / 03期

关键词：

D O I：

10.1016/j.lungcan.2006.03.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：373 / 373

页数：1

共 4 条

[1] Case 2. Response to erlotinib after failure of gefitinib in a patient with advanced non-small-cell lung carcinoma [J].

Garfield, DH .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7738-7740

[2] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib [J].

Kobayashi, S ;

Boggon, TJ ;

Dayaram, T ;

Janne, PA ;

Kocher, O ;

Meyerson, M ;

Johnson, BE ;

Eck, MJ ;

Tenen, DG ;

Halmos, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :786-792

[3]

RIELY GJ, 2005, LUNG CANC PRINCIPLES, V5

[4] Erlotinib in previously treated non-small-cell lung cancer [J].

Shepherd, FA ;

Pereira, JR ;

Ciuleanu, T ;

Tan, EH ;

Hirsh, V ;

Thongprasert, S ;

Campos, D ;

Maoleekoonpiroj, S ;

Smylie, M ;

Martins, R ;

van Kooten, M ;

Dediu, M ;

Findlay, B ;

Tu, DS ;

Johnston, D ;

Bezjak, A ;

Clark, G ;

Santabárbara, P ;

Seymour, L .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :123-132

← 1 →